Enable AccessibilityEnable Accessibility

Director/PDMR Share Dealings

June 28, 2013

Shire plc (LSE: SHP, NASDAQ: SHPG), (the “Company”) announces that today Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, have been acquired for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from April 1 to June 30, 2013.

  Type of Security (1)  Number of Shares/ADSs 
William Burns   Shares  243
Dr. Steven Gillis  ADSs  78
Dr. David Ginsburg  ADSs  73
David Kappler  Shares  288
Susan Kilsby  ADSs  74
Anne Minto  Shares  253
David Stout  ADSs  81

(1) One ADS is equal to three Shares


The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively, at prices of £20.90 per Share and $95.20 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary


For further information please contact:

Investor Relations
Eric Rojas   
[email protected]
+1 781 482 0999

Sarah Elton-Farr   
[email protected]
+44 1256 894157

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

Click here for the PDF version of this press release.